Japan OKs World’s 1st iPS Cell Treatments
Tokyo, March 6 (Jiji Press)–Japan’s health ministry said Friday it has conditionally approved production and sales of two novel regenerative therapies capitalizing on induced pluripotent stem cells. The world’s first permission of iPS cell-derived medicine, albeit provisional, was given to Tokyo-based startup